| [1] |
中国医师协会器官移植医师分会，中华医学会器官移植学分会肝移植学组. 中国肝移植受者肾损伤管理专家共识(2017版) [J]. 中华消化外科杂志，2017, 16(4): 319-326.
|
| [2] |
叶林森，张英才，赵辉，等. 肝移植后存活超过5年的受者免疫抑制剂相关并发症的单中心研究[J]. 中华器官移植杂志，2016, 37(7): 415-420.
|
| [3] |
Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity [J]. Clin J Am Soc Nephrol, 2009, 4(2): 481-508.
|
| [4] |
Vivarelli M, Massella L, Ruggiero B, et al. Minimal change disease [J]. Clin J Am Soc Nephrol, 2017, 12(2): 332-345.
|
| [5] |
Lionaki S, Liapis G, Boletis JN. Pathogenesis and management of acute kidney injury in patients with nephrotic syndrome due to primary glomerulopathies [J]. Medicina (Kaunas), 2019, 55(7): 365.
|
| [6] |
Meyrier A, Niaudet P. Acute kidney injury complicating nephrotic syndrome of minimal change disease [J]. Kidney Int, 2018, 94(5): 861-869.
|
| [7] |
Maas RJ, Deegens JK, Wetzels JF. Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future [J]. Nephrol Dial Transplant, 2014, 29(12): 2207-2216.
|
| [8] |
Gauckler P, Shin JI, Alberici F, et al. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - what is known and what is still unknown? [J]. Autoimmun Rev, 2020, 19(11): 102671.
|
| [9] |
Nakayama M, Katafuchi R, Yanase T, et al. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome [J]. Am J Kidney Dis, 2002, 39(3): 503-512.
|
| [10] |
Fujimoto S, Yamamoto Y, Hisanaga S, et al. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse [J]. Am J Kidney Dis, 1991, 17(6): 687-692.
|
| [11] |
Dasilva I, Huerta A, Quintana L, et al. Rituximab for steroid-dependent or frequently relapsing idiopathic nephrotic syndrome in adults: a retrospective, multicenter study in Spain [J]. BioDrugs, 2017, 31(3): 239-249.
|
| [12] |
Papakrivopoulou E, Shendi AM, Salama AD, et al. Effective treatment with rituximab for the maintenance of remission in frequently relapsing minimal change disease [J]. Nephrology (Carlton), 2016, 21(10): 893-900.
|
| [13] |
King C, Logan S, Smith SW, et al. The efficacy of rituximab in adult frequently relapsing minimal change disease [J]. Clin Kidney J, 2017, 10(1): 16-19.
|